Tech Company Financing Transactions
Exsure Funding Round
Exsure secured a $350 thousand Seed financing round on 1/22/2025. Investors included Unicorn India Ventures and private investors.
Transaction Overview
Company Name
Announced On
1/22/2025
Transaction Type
Venture Equity
Amount
$350,000
Round
Seed
Investors
Unicorn India Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to complete non-clinical study with its Exosome-based drug delivery vehicle, expand globally its in-house manufactured R&D products, and promote Exosure, Leucosure, PlantExosure and Dr Berries.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Bhubaneswar, Undisclosed
India
Bhubaneswar, Undisclosed
India
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Our commitment is to provide best quality research oriented services, developing unique products for Biotechnology research and creating India's first anti-cancer drug delivery platform that will transform conventional chemotherapy into the next generation of exosome-based targeted chemotherapy saving millions of lives of cancer patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Abhishek Dutta
Founder
Swastika Paul
Browse more venture capital transactions:
Prev: 1/22/2025: Clay venture capital transaction
Next: 1/22/2025: Kaya AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs